1465908-73-9

Tasipimidine sulfate is an orally active and selective α2A-adrenoceptor agonist with a pEC50 of 7.57 against human α2A-adrenoceptor. Tasipimidine sulfate can be used for situational anxiety and fear research[1].

human α2A-adrenoceptor: 7.57 (pEC₅₀); rodent α2D-adrenoceptor: 6.56 (pEC₅₀); human α2C-adrenoceptor: 6.29 (pEC₅₀); human α2B-adrenoceptor: 6.00 (pEC₅₀)

4°C, away from moisture

[1] Lehtim?ki J, et al. Tasipimidine-the pharmacological profile of a novel orally active selective α2A-adrenoceptor agonist. Eur J Pharmacol. 2022 May 15;923:174949. DOI:10.1016/j.ejphar.2022.174949